Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 2,691 | 2,809 | 4,592 | 3,038 | 300 |
| Gross Profit | 2,691 | 2,809 | 4,592 | 3,038 | 300 |
| Operating Expenses | 8,686 | 15,373 | 35,544 | 7,049 | 4,817 |
| Operating Income | -5,995 | -12,565 | -30,952 | -4,011 | -4,517 |
| Interest Expense | 1 | 2 | 2 | 97 | 61 |
| Other Income | 1,830 | 624 | -483 | 4 | -1 |
| Pre-tax Income | -4,165 | -11,943 | -31,438 | -4,104 | -4,579 |
| Income Tax | -992 | -3,112 | -1,533 | -994 | N/A |
| Net Income Continuous | -3,174 | -8,831 | -29,905 | -3,110 | -4,579 |
| Net Income | $-3,174 | $-8,831 | $-29,905 | $-3,110 | $-4,579 |
| EPS Basic Total Ops | -7.49 | -29.11 | -61.57 | -7.81 | -20.42 |
| EPS Basic Continuous Ops | -4.69 | -22.26 | -57.73 | -7.63 | -19.88 |
| EPS Diluted Total Ops | -7.49 | -29.11 | -61.57 | -7.81 | -20.42 |
| EPS Diluted Continuous Ops | -4.69 | -22.26 | -57.73 | -7.63 | -19.88 |
| EBITDA(a) | $-5,464 | $-3,207 | $-4,315 | $-3,973 | $-4,492 |